Assignee
ROME THERAPEUTICS INC
US·1 granted patent·9 pending applications·0 citations·filing 2022–2024
Top patents by PatentIndex Score
10 records- 0177US2025145654A1Compounds and methods for treating diseaseROME THERAPEUTICS INC·Filed 2024·Application pending·0 cites
- 0274US12187758B2Compounds and methods for treating diseaseROME THERAPEUTICS INC·Filed 2023·Granted Jan 7, 2025·0 cites·26 claims
- 0369US2023295212A1Compounds and methods for treating diseaseROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0460US2025282803A1Didehydro-3'-deoxy-4'-ethynylthymidines and related compounds and their use in treating medical conditionsROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0558US2025186475A1Methods of treating medical conditions using islatravir or a related compoundROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0658US2025186467A1Methods of treating medical conditions using stampidine or a related compoundROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0757US2025170158A1Methods of treating medical conditions using censavudine or a related compoundROME THERAPEUTICS INC·Filed 2023·Application pending·0 cites
- 0855US2025268925A1Methods of treating medical conditions and inhibiting line1 reverse transcriptase using a substituted adeninyl-propyloxy phosphonic acid or related compoundROME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 0954US2024366649A14-ethynyl-3-hydroxy-tetrahydrofuranyl-adenine phosphoramidates and related compounds and their use in treating medical conditionsROME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
- 1054US2024261317A1Methods of treating medical conditions and inhibiting line1 reverse transcriptaseusing a substituted 4-fluoro-2,5-dihydrofuranyl phosphonic acid or related compoundROME THERAPEUTICS INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ROME THERAPEUTICS INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →